NCT05405907View on ClinicalTrials.gov

Evaluation of the Haemostatic Agent Purabond in ENT TORS

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Hemorrhage
Interventions
OTHER

PuraBond haemostatic agent

Application of Purabond to surgical field

Trial Locations (1)

B15 2TH

University Hospitals Birmingham NHS Trust, Birmingham

All Listed Sponsors
lead

University Hospital Birmingham NHS Foundation Trust

OTHER

NCT05405907 - Evaluation of the Haemostatic Agent Purabond in ENT TORS | Biotech Hunter | Biotech Hunter